AU5473599A - Methods for promoting survival of myelin producing cells - Google Patents

Methods for promoting survival of myelin producing cells

Info

Publication number
AU5473599A
AU5473599A AU54735/99A AU5473599A AU5473599A AU 5473599 A AU5473599 A AU 5473599A AU 54735/99 A AU54735/99 A AU 54735/99A AU 5473599 A AU5473599 A AU 5473599A AU 5473599 A AU5473599 A AU 5473599A
Authority
AU
Australia
Prior art keywords
methods
producing cells
promoting survival
myelin producing
myelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54735/99A
Inventor
Leath E. Begleiter
Jerold J. M. Chun
Joshua A. Weiner
Philip L. Wickens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allelix Biopharmaceuticals Inc
University of California
Original Assignee
JEROLD J M CHUN
LEATH E BEGLEITER
Allelix Biopharmaceuticals Inc
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JEROLD J M CHUN, LEATH E BEGLEITER, Allelix Biopharmaceuticals Inc, University of California filed Critical JEROLD J M CHUN
Publication of AU5473599A publication Critical patent/AU5473599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0622Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54735/99A 1998-08-10 1999-08-10 Methods for promoting survival of myelin producing cells Abandoned AU5473599A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US9600898P 1998-08-10 1998-08-10
US60096008 1998-08-10
US9692498P 1998-08-18 1998-08-18
US60096924 1998-08-18
US09/153,464 US6150345A (en) 1998-08-10 1998-09-15 Methods for promoting survival of myelin producing cells
US09153464 1998-09-15
PCT/US1999/018069 WO2000009139A2 (en) 1998-08-10 1999-08-10 Methods for promoting survival of myelin producing cells

Publications (1)

Publication Number Publication Date
AU5473599A true AU5473599A (en) 2000-03-06

Family

ID=27378041

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54735/99A Abandoned AU5473599A (en) 1998-08-10 1999-08-10 Methods for promoting survival of myelin producing cells

Country Status (3)

Country Link
US (1) US6150345A (en)
AU (1) AU5473599A (en)
WO (1) WO2000009139A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2349593A1 (en) * 1998-11-05 2000-05-11 The Regents Of The University Of Michigan S100 proteins and autoantibodies as serum markers for cancer
IL129178A0 (en) * 1999-03-25 2000-02-17 Yeda Res & Dev Induction of nerve generation
IL129179A0 (en) * 1999-03-25 2000-02-17 Yeda Res & Dev Cyclic glycerophosphates and analogs thereof
JP4815063B2 (en) * 2001-04-13 2011-11-16 きみ子 室伏 Drugs for promoting the proliferation, differentiation and / or survival of glial cells containing cyclic phosphatidic acid
JP4836345B2 (en) * 2001-04-13 2011-12-14 きみ子 室伏 Neuronal survival promoter containing cyclic phosphatidic acid derivative
JP4163007B2 (en) * 2001-05-21 2008-10-08 きみ子 室伏 Cancer metastasis inhibitor containing carbacyclic phosphatidic acid derivative
AU2003233119A1 (en) * 2002-05-08 2003-11-11 Neuronova Ab Modulation of neural stem cells with s1p or lpa receptor agonists
JP2006505248A (en) * 2002-06-07 2006-02-16 イーエス・セル・インターナショナル・プライヴェート・リミテッド Methods for controlling differentiation in stem cells
AU2003229140B2 (en) * 2002-06-07 2010-05-27 Es Cell International Pte Ltd Methods of regulating differentiation in stem cells
JP4162927B2 (en) * 2002-06-11 2008-10-08 きみ子 室伏 Carbacyclic phosphatidic acid derivatives
SI1536827T1 (en) 2002-08-14 2009-06-30 Silence Therapeutics Ag Use of protein kinase n beta
US20040241839A1 (en) * 2003-04-11 2004-12-02 Svetlov Stanislav I. Culturing neural stem cells
KR101366482B1 (en) 2004-12-27 2014-02-21 사일런스 테라퓨틱스 아게 Coated lipid complexes and their use
CA2658550C (en) * 2006-07-21 2018-06-19 Silence Therapeutics Ag Means for inhibiting the expression of protein kinase 3
CN101358609A (en) * 2007-08-03 2009-02-04 富准精密工业(深圳)有限公司 Fan rotor
WO2009100116A1 (en) * 2008-02-04 2009-08-13 Medical College Of Georgia Research Institute Oligodendrocyte precursor cell composition and methods of use
US20100330555A1 (en) * 2009-06-25 2010-12-30 General Electric Company Accuracy fluorescence in-situ hybridization assay of samples with apoptotic cells
WO2011065480A1 (en) * 2009-11-26 2011-06-03 国立大学法人お茶の水女子大学 Nerve cell death inhibitor
US10413559B2 (en) 2013-01-28 2019-09-17 Ochanomizu University Method for treating demyelinating disease
KR101514878B1 (en) * 2013-05-14 2015-04-24 건국대학교 산학협력단 Compound from the Rice Straw Extract and Its Algicidal Activity Against Blue-Green Algae
KR20220082117A (en) * 2019-02-21 2022-06-16 위니베르시테 끌로드 베르나르 리옹 Ⅰ Structured molecular vectors for anti-inflammatory compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238965A (en) * 1991-05-31 1993-08-24 The Procter & Gamble Company Methods of using lysophosphatidic acids for regulating skin wrinkles
US5565439A (en) * 1992-11-24 1996-10-15 The Procter & Gamble Company Methods of using lysophosphatidic acid for treating hyperproliferative conditions

Also Published As

Publication number Publication date
WO2000009139A3 (en) 2000-05-18
US6150345A (en) 2000-11-21
WO2000009139A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
AU5473599A (en) Methods for promoting survival of myelin producing cells
AU5731400A (en) Methods of preparing electrochemical cells
AU1796601A (en) Methods of preparing electrochemical cells
AU3181099A (en) Storage-stable compositions useful for the production of structural foams
AU2193500A (en) Methods of preparing prismatic cells and prismatic cells prepared by such methods
AU4973699A (en) Simplified process for producing nanoporous silica
AU2851699A (en) Method of producing ceramic foams
AU2557500A (en) Methods of making compounds
AU2002241793A1 (en) Process for the preparation of organoclays
AU6830900A (en) Method for the production of three-dimensional or flat structures
AU3110500A (en) Cell matrix plaques of initial bone formation
AU1796501A (en) Methods of preparing electrochemical cells
AU3467099A (en) Methods for production of therapeutic cytokines
AU1080899A (en) Methods for increasing schwann cell survival
AU5370599A (en) Method for producing highly pure libf4
AU8627798A (en) Biocatalytic process for the preparation of 3-0-acyl-flavonoids
AU1658800A (en) Method for producing bisphenol-a
AU6083898A (en) Method for the manufacture of photovoltaic cell
AU1720501A (en) Methods of producing novel enzymes
AU1797100A (en) Process for producing apelin
AU1223500A (en) Methods for stimulating the regeneration of inner ear cells
AU2001241816A1 (en) Methods for promoting production of myelin by schwann cells
AU1274701A (en) Method of producing polycarbonates
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU4010000A (en) Epimerization reaction for the production of r-fluoxetine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase